9-96302143-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000643789.1(ENSG00000285269):​n.*1638A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.202 in 1,606,212 control chromosomes in the GnomAD database, including 36,679 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.21 ( 3510 hom., cov: 31)
Exomes 𝑓: 0.20 ( 33169 hom. )

Consequence

ENSG00000285269
ENST00000643789.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.252

Publications

8 publications found
Variant links:
Genes affected
HSD17B3 (HGNC:5212): (hydroxysteroid 17-beta dehydrogenase 3) This isoform of 17 beta-hydroxysteroid dehydrogenase is expressed predominantly in the testis and catalyzes the conversion of androstenedione to testosterone. It preferentially uses NADP as cofactor. Deficiency can result in male pseudohermaphroditism with gynecomastia. [provided by RefSeq, Jul 2008]
HSD17B3 Gene-Disease associations (from GenCC):
  • 46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.458 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HSD17B3NM_000197.2 linkc.-39A>G 5_prime_UTR_variant Exon 1 of 11 ENST00000375263.8 NP_000188.1 P37058-1Q6FH62
SLC35D2-HSD17B3NR_182427.1 linkn.2729A>G non_coding_transcript_exon_variant Exon 16 of 26

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENSG00000285269ENST00000643789.1 linkn.*1638A>G non_coding_transcript_exon_variant Exon 12 of 22 ENSP00000494818.1 A0A2R8Y5X9
HSD17B3ENST00000375263.8 linkc.-39A>G 5_prime_UTR_variant Exon 1 of 11 1 NM_000197.2 ENSP00000364412.3 P37058-1
ENSG00000285269ENST00000643789.1 linkn.*1638A>G 3_prime_UTR_variant Exon 12 of 22 ENSP00000494818.1 A0A2R8Y5X9

Frequencies

GnomAD3 genomes
AF:
0.205
AC:
31172
AN:
151904
Hom.:
3511
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.171
Gnomad AMI
AF:
0.170
Gnomad AMR
AF:
0.237
Gnomad ASJ
AF:
0.241
Gnomad EAS
AF:
0.474
Gnomad SAS
AF:
0.369
Gnomad FIN
AF:
0.256
Gnomad MID
AF:
0.263
Gnomad NFE
AF:
0.177
Gnomad OTH
AF:
0.207
GnomAD2 exomes
AF:
0.253
AC:
60253
AN:
238376
AF XY:
0.255
show subpopulations
Gnomad AFR exome
AF:
0.172
Gnomad AMR exome
AF:
0.276
Gnomad ASJ exome
AF:
0.253
Gnomad EAS exome
AF:
0.502
Gnomad FIN exome
AF:
0.255
Gnomad NFE exome
AF:
0.182
Gnomad OTH exome
AF:
0.225
GnomAD4 exome
AF:
0.201
AC:
292802
AN:
1454190
Hom.:
33169
Cov.:
32
AF XY:
0.207
AC XY:
149299
AN XY:
722948
show subpopulations
African (AFR)
AF:
0.178
AC:
5922
AN:
33188
American (AMR)
AF:
0.269
AC:
11760
AN:
43728
Ashkenazi Jewish (ASJ)
AF:
0.256
AC:
6674
AN:
26028
East Asian (EAS)
AF:
0.457
AC:
17921
AN:
39224
South Asian (SAS)
AF:
0.373
AC:
31828
AN:
85302
European-Finnish (FIN)
AF:
0.254
AC:
13487
AN:
53052
Middle Eastern (MID)
AF:
0.243
AC:
1367
AN:
5624
European-Non Finnish (NFE)
AF:
0.172
AC:
190652
AN:
1107966
Other (OTH)
AF:
0.220
AC:
13191
AN:
60078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
12334
24667
37001
49334
61668
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7046
14092
21138
28184
35230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.205
AC:
31199
AN:
152022
Hom.:
3510
Cov.:
31
AF XY:
0.214
AC XY:
15882
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.171
AC:
7092
AN:
41470
American (AMR)
AF:
0.238
AC:
3628
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.241
AC:
835
AN:
3468
East Asian (EAS)
AF:
0.473
AC:
2431
AN:
5136
South Asian (SAS)
AF:
0.368
AC:
1773
AN:
4816
European-Finnish (FIN)
AF:
0.256
AC:
2711
AN:
10570
Middle Eastern (MID)
AF:
0.272
AC:
80
AN:
294
European-Non Finnish (NFE)
AF:
0.177
AC:
12059
AN:
67974
Other (OTH)
AF:
0.206
AC:
435
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1240
2481
3721
4962
6202
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
342
684
1026
1368
1710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.189
Hom.:
4941
Bravo
AF:
0.203
Asia WGS
AF:
0.362
AC:
1258
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 25, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Testosterone 17-beta-dehydrogenase deficiency Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
3.7
DANN
Benign
0.63
PhyloP100
0.25
PromoterAI
-0.013
Neutral
Mutation Taster
=298/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2066474; hg19: chr9-99064425; COSMIC: COSV64556740; API